Navigation Links
Intellect Neurosciences Issues Letter to Shareholders
Date:10/14/2011

NEW YORK, Oct. 14, 2011 /PRNewswire/ -- Intellect Neurosciences, Inc. (OTCBB: ILNS), a biopharmaceutical company engaged in the discovery and development of disease-modifying therapeutic agents for the treatment of Alzheimer's and other neurological diseases today issued the following Letter to Shareholders from Dr. Daniel Chain, Chairman and CEO.

Dear Shareholder,

I would like to take this opportunity to update you about pertinent corporate and industry developments contemporaneous with the current filing of our quarterly financial statements with the SEC.

Of special note is our recent transaction with ViroPharma Inc., which was announced September 30, 2011. Intellect granted an exclusive license to ViroPharma regarding certain of Intellect's licensed patents and patent applications related to Intellect's clinical stage drug candidate, OX1, an extremely potent antioxidant molecule that has been demonstrated to protect nerve cells in the brain from highly oxidizing neurotoxins. ViroPharma plans to develop and commercialize OX1 as a treatment of Friedreich's Ataxia and possibly other diseases for which OX1 may qualify for orphan drug designation.  Under the terms of the license agreement, Intellect received an upfront payment of $6.5 million, and will receive up to an additional $120 million based on defined events and a tiered royalty of up to a maximum of low double digits based on annual net sales.  In exchange, Intellect transferred to ViroPharma all of Intellect's intellectual property rights, data and know-how, assembled over several years related to its OX1 research and development program.  NYU Medical School and University of South Alabama, which own certain patents in relation to OX1, are entitled to a portion of the revenues received by Intellect from ViroPharma pursuant to an exclusive license agreement between Intellect Neurosciences and those universities.

I am particularly gratified by the interest shown i
'/>"/>

SOURCE Intellect Neurosciences, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Intellect Neurosciences CEO to be Featured on Wall Street Reporter
2. ViroPharma Licenses Rights From Intellect Neurosciences for Product Candidate for Friedreichs Ataxia
3. IRIDEX Licenses the Exclusive Rights to Ophthalmology Products and Intellectual Property from Ocunetics, Inc.
4. PILMA Vows to Redouble Support for Increased Protections Against Intellectual Property Theft
5. Dehaier Strengthens Intellectual Property Portfolio
6. NMT Medical, Inc. Adds Intellectual Property to Its Sealed Bid Sale of Friday, June 10, 2011 at Twelve OClock Noon
7. GT Life Sciences Broadens Intellectual Property Portfolio with Issuance of U.S. Patent on Core Computational Systems and Methods for Genomic-based Metabolic Modeling
8. Inovio Pharmaceuticals Market-Leading Intellectual Property Recognized by MDB Capital Award
9. NMT Medical, Inc. Sealed Bid Sale of its Intellectual Property to Take Place Friday, June 10, 2011 at Twelve OClock Noon
10. Software Development Firms New Intellectual Property Group, Blue Horseshoe IP Creates Solutions to Help Customers Optimize Supply Chain
11. As Pharmaceutical Supply Chain Goes Global, Threat of Counterfeiting, Intellectual Property Theft and Contamination Rises, Finds New Report; New Supply Chain Management Strategies Needed
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2014)... Conn. , July 29, 2014 Numotion,s Board ... Mike Swinford will be the company,s new Chief ... highly successful 22-year career at GE where he worked primarily ... in annual revenue to over $5 billion. His most recent ... Services. "I am thrilled to join Numotion," ...
(Date:7/29/2014)... July 29, 2014 McGraw-Hill Education Professional, a ... science, technical, and medical communities, has announced the launch ... mobile application of the world-renowned medical education platform. ... AccessMedicine App , available for download onto all iOS ... able to gain access to valuable AccessMedicine ...
(Date:7/29/2014)... DIEGO , July 29, 2014  Neurocrine Biosciences, ... the Company will report its second quarter 2014 financial ... 6, 2014.  Neurocrine will then host a live conference ... provide a Company update Thursday morning, August 7, 2014 ... Participants can access the live conference call ...
Breaking Medicine Technology:Numotion Names Mike Swinford CEO 2McGraw-Hill Education Professional's AccessMedicine App Delivers Instant Access to Essential Diagnostic Tools 2McGraw-Hill Education Professional's AccessMedicine App Delivers Instant Access to Essential Diagnostic Tools 3Neurocrine Biosciences Announces Conference Call And Webcast To Report Second Quarter 2014 Financial Results 2
... on the short arm of chromosome 6 (6p21.3), is a ... region is the human equivalent of the Major Histocompatibility Complex ... serve as the backbone of antigen presentation. The Class ... T-cells, are expressed by genes located in the HLA-A, -B ...
... the level of blood oxygenation can be an ... levels in the clinical setting is often desirable. ... sophisticated technology into easily used point-of-care devices, recent ... hemoglobin values., ,HemoCue, Inc., Lake Forest, Calif., says ...
Cached Medicine Technology:The Past, Present and Future of HLA Typing 2The Past, Present and Future of HLA Typing 3Hemoglobin Testing at the Point of Care 2Hemoglobin Testing at the Point of Care 3
(Date:7/29/2014)... the injuries and aptitudes of Vietnam War veterans who ... tackling -- and beginning to answer -- longstanding questions ... that brain regions that contribute to optimal social functioning ... intelligence. This finding bolsters the view that general intelligence ... life. , The findings are reported ...
(Date:7/29/2014)... 29, 2014 According to a new ... leading global authority in medical device market research, the ... to over $8 billion by 2018. This growth ... the transcatheter heart valve market, which is comprised of ... transcatheter mitral valve repair (TMVR) segments. , There are ...
(Date:7/29/2014)... 2014 Doug and Sandra Williams have been ... selling their grow-your-own log kits for almost that long. Naturally, ... and a treat for their guests. A new video ... the Lost Creek Mushroom Farm online coverage. , They started ... soon turned to selling the logs instead of the mushrooms, ...
(Date:7/29/2014)... FL (PRWEB) July 29, 2014 Officials with ... launch its products in the UK in September. , Craig ... will be available Sept. 7 on Amazon.co.uk. , “Demand for ... growing and we are truly looking forward to serving the ... include OZ Naturals bestselling Vitamin C serum and ...
(Date:7/29/2014)... 29, 2014 Regents Health Resources, a ... has brought health care industry veteran Daryl Demonbreun and ... help lead the company’s ambitious plans to grow into ... has been moving along at a steady pace for ... up a notch,” says Bob Maier, founder and chief ...
Breaking Medicine News(10 mins):Health News:Team studies the social origins of intelligence in the brain 2Health News:Team studies the social origins of intelligence in the brain 3Health News:Global Transcatheter Heart Valve Devices Market Outlook to 2018: Breakthrough Developments led by Abbott, Edwards LifeSciences and Medtronic 2Health News:Global Transcatheter Heart Valve Devices Market Outlook to 2018: Breakthrough Developments led by Abbott, Edwards LifeSciences and Medtronic 3Health News:Lost Creek Mushroom Farm Cooks Up a Company Dish from Shiitake Mushrooms Grown on Logs With Grow-Your-Own Log Kits 2Health News:Lost Creek Mushroom Farm Cooks Up a Company Dish from Shiitake Mushrooms Grown on Logs With Grow-Your-Own Log Kits 3Health News:Lost Creek Mushroom Farm Cooks Up a Company Dish from Shiitake Mushrooms Grown on Logs With Grow-Your-Own Log Kits 4Health News:OZ Naturals to Launch Its Products in the UK 2Health News:Sferrella and Demonbruen Join Regents Health Resources 2
... Calif.) UC Davis researchers have developed an accurate ... arrhythmia, or abnormal heart rhythm, before they are used ... in the Aug. 31 issue of the journal ... anti-arrhythmia medications early in the drug-development pipeline and eventually ...
... nothing more than to get back home to loved ... more emotionally taxing than the deployment. Returning service ... symptoms and relationship distress, and research shows the two ... Knobloch (pronounced kuh-NO-block). That,s not a good thing, since ...
... intent of the ACA is to control health care ... who need it most," said Alliance Director Christine Ferguson, ... worsening health outcomes and equally alarming cost projections, leaving ... At the core of the Task Force,s recommendations is ...
... -- A language barrier may not prevent Spanish-speaking patients ... for Healthcare Research and Quality (AHRQ) said it,s now ... the benefits and risks of certain heart medications. ... of AHRQ,s ongoing effort to give Hispanics the knowledge ...
... patients, struggle to find time and motivation to exercise. ... some additional pressure and responsibility: nurses, attitudes can influence ... "Nurses should model healthy exercise behavior," said Joyce Fitzpatrick, ... Journal of Nursing Practice and the Elizabeth Brooks ...
... INDIANAPOLIS Analysis by Indiana University School of Medicine ... in changes in American Academy of Pediatrics recommendations for ... is diagnosed and treated. This change will affect thousands ... IU School of Medicine investigators argue against exposing all ...
Cached Medicine News:Health News:UC Davis researchers develop computer model for testing heart-disease drugs 2Health News:UC Davis researchers develop computer model for testing heart-disease drugs 3Health News:Study offers insight for returning troops and their relationships 2Health News:Study offers insight for returning troops and their relationships 3Health News:STOP Obesity Alliance Task Force urges HHS to give obesity equal weight in essential health benefits 2Health News:U.S. Offers Health-Care Pamphlets in Spanish 2Health News:Calling nurses to exercise as role models for their patients 2Health News:IU analysis changing diagnosis and management of initial UTIs in young children 2
... assays can be used to screen ... which are associated with various systemic ... erythematosus (Lupus), Sjgren's syndrome, mixed connective ... polymyositis, dermatomyositis, and Raynaud's phenomenon. They ...
... Indirect Fluorescence Assay (IFA) for IgG ... for the qualitative and semi-quantitative detection ... in human serum. Detection of ANA ... an aid in the diagnosis of ...
... Assay measures changes in platelet function ... (Plavix). It uses a specific activator ... inhibits. The assay has not been ... assay is available for Research Use ...
The Wide Angle Twin Mag NP combines the performance of two instruments to deliver unequalled power and versatility into the hands of eye care professionals....
Medicine Products: